Scope Fluidics Spolka Akcyjna (WAR:SCP) Shares Outstanding (EOP): 3.17 Mil (As of Mar. 2026)


WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
49 GF Score
Price zł120.00
GF Value zł129.86
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP)?

Scope Fluidics Spolka Akcyjna WAR:SCP -1.32% 49 Shares Outstanding (EOP) is 3.17 Mil as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 49/100 and a GF Value™ of zł129.86 (Fairly Valued). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Scope Fluidics Spolka Akcyjna's shares outstanding for the quarter that ended in Mar. 2026 was 3.17 Mil.

Scope Fluidics Spolka Akcyjna's quarterly shares outstanding stayed the same from Dec. 2025 (3.17 Mil) to Mar. 2026 (3.17 Mil).

Scope Fluidics Spolka Akcyjna's annual shares outstanding increased from Dec. 2024 (2.73 Mil) to Dec. 2025 (3.17 Mil). It means Scope Fluidics Spolka Akcyjna issued new shares from Dec. 2024 to Dec. 2025 .


Scope Fluidics Spolka Akcyjna  (WAR:SCP) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP) Related Terms


Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP) Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.69 2.73 2.73 2.73 3.17

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 2.73 2.73 3.17 3.17

WAR:SCP vs TMO, DHR, IDXX: Shares Outstanding (EOP) Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) falls into.


WAR:SCP
49GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 3.17 Mil mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Shares Outstanding (EOP) of 3.17 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) too high?
Scope Fluidics Spolka Akcyjna's current Shares Outstanding (EOP) is 3.17 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Shares Outstanding (EOP) of 3.17 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Diagnostics & Research company?
A good Shares Outstanding (EOP) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Shares Outstanding (EOP) is 3.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł129.86, compared to a current price of zł120.00 — trading 7.6% below its estimated fair value. The current Shares Outstanding (EOP) is 3.17 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Shares Outstanding (EOP) is 3.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł120.00 is trading 7.6% below its estimated GF Value™ of zł129.86. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Shares Outstanding (EOP): 3.17 Mil
  • GF Value™: zł129.86 vs. price of zł120.00 (7.6% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
49GF Score

Get the complete analysis for WAR:SCP

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł120.00
Price
zł129.86
GF Value